康弘药业：未来将从四方面开展工作应对股价影响因素

Core Viewpoint - The company acknowledges the decline in its stock price and outlines measures to stabilize it, emphasizing a commitment to improving operational performance and enhancing market recognition [1] Group 1: Company Measures - The company will focus on deepening its core business to enhance operational performance [1] - It aims to strengthen information disclosure to increase market recognition [1] - The company plans to improve corporate governance to protect shareholder rights [1] - It will pay attention to market dynamics to communicate the company's value effectively [1]